Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Why Co-Diagnostics Blasted 21% Higher on Thursday
06:28pm, Thursday, 22'nd Jul 2021
The company was awarded a patent from a relatively affluent Asian country.
Why Co-Diagnostics Shares Are Skyrocketing Today
02:33pm, Thursday, 22'nd Jul 2021
Co-Diagnostics Inc (NASDAQ:CODX) shares are trading higher by 26.3% at $10.99 Thursday afternoon. The stock spiked earlier following reports suggesting the Biden Administration will announce it is d
Co-Diagnostics strengthens intellectual property portfolio with South Korean patent award for its CoPrimer technology
11:49am, Thursday, 22'nd Jul 2021
Co-Diagnostics Inc has strengthened its intellectual property portfolio after being awarded a patent in the Republic of Korea for the company's CoPrimer technology. Developed in 2013, Co-Diagnostics'
Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent
09:30am, Thursday, 22'nd Jul 2021
SALT LAKE CITY, July 22, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
CODX Stock Increased 9.67%: Why It Happened
06:55am, Tuesday, 20'th Jul 2021
The stock price of Co-Diagnostics Inc (NASDAQ: CODX) increased by 9.67% yesterday. This is why it happened.
Strength Seen in CoDiagnostics, Inc. (CODX): Can Its 9.7% Jump Turn into More Strength?
04:35am, Tuesday, 20'th Jul 2021
CoDiagnostics, Inc. (CODX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
Why Coronavirus Stocks Are Zooming Higher Today
03:12pm, Monday, 19'th Jul 2021
The surge in cases and deaths could significantly ramp up demand for these companies' existing and pipeline products.
Are Investors Undervaluing CoDiagnostics, Inc. (CODX) Right Now?
12:46pm, Thursday, 01'st Jul 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Co-Diagnostics, Inc. (NASDAQ:CODX) has announced that its Logix Smart SARS-CoV-2 DS (Direct Saliva) test has obtained regulatory authorization to be sold as an in vitro diagnostic (IVD) for the diagno
Co-Diagnostics, Inc. (NASDAQ:CODX) has announced that its Logix Smart SARS-CoV-2 DS (Direct Saliva) test has obtained regulatory authorization to be sold as an in vitro diagnostic (IVD) for the diagno
Co-Diagnostics, Inc. (NASDAQ:CODX) has announced that its Logix Smart SARS-CoV-2 DS (Direct Saliva) test has obtained regulatory authorization to be sold as an in vitro diagnostic (IVD) for the diagno
Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test
10:30am, Friday, 18'th Jun 2021
SALT LAKE CITY, June 18, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
Wall Street takes a turn for the worse as investors eye Fed
12:20pm, Tuesday, 15'th Jun 2021
12:15pm: The Dow was down 161 points, 0.5%, at 34,233 at midday. The Nasdaq lost 85 points, 0.6%, to 14,088, and the S&P 500 ticked down 11 points, 0.3%, to 4,244.
Co-Diagnostics says it will be presenting virtually at two conferences this week
10:49am, Tuesday, 15'th Jun 2021
Co-Diagnostics, Inc. (NASDAQ:CODX) said it will be presenting virtually this week at the 28th International Biodetection Technologies Conference, as well as hosting a virtual booth at the 65th Annual
Co-Diagnostics says it will be presenting virtually at two conferences virtually this week
09:33am, Tuesday, 15'th Jun 2021
Co-Diagnostics, Inc. (NASDAQ:CODX) said it will be presenting virtually this week at the 28th International Biodetection Technologies Conference, as well as hosting a virtual booth at the 65th Annual
